Arabic Arabic English English French French German German
dark

Imperative Care Raises $260 Million to Advance Innovations that Elevate Stroke Care

Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners L.P. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada’s National Research Council

Next Post

NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol ER) to Treat Narcolepsy

Related Posts
Total
0
Share